The Wellness, Health News
Nutrition
Diet science, supplements, GLP-1s
9 Jul 2026Obesity Drugs Show Limited Quality-of-Life Gains
A large meta-analysis published in The BMJ found that leading obesity medications produced meaningful weight loss but did not translate that into measurable improvements in quality of life or heart health.
- 4 Jul 2026
Wegovy Approved for Liver Disease by UK Regulator
The UK medicines regulator has granted approval for semaglutide injection (Wegovy) as a treatment for a progressive form of liver disease in adult patients.
26 Jun 2026Wegovy Weight-Loss Drug to Launch as Daily UK Pill
Wegovy, the weight-loss drug currently administered by weekly injection, is set to become available in oral tablet form in the UK for the first time, manufacturer Novo Nordisk has announced.
- 23 Jun 2026
Obesity Drug Development Standards Under Review
A piece published in Nature Medicine suggests that the frameworks used to evaluate obesity treatments are attracting fresh scrutiny, pointing to a potentially shifting landscape in this area of pharmacological research.
- 23 Jun 2026
Obesity Drug Development Standards May Be Shifting
A recently published commentary in Nature Medicine suggests that the criteria used to evaluate obesity treatments are undergoing a meaningful reappraisal, a development that could reshape the field broadly.
- 19 Jun 2026
Oral GLP-1 Drugs Enter the Obesity Treatment Debate
A comment published in The Lancet explores the therapeutic potential of oral small-molecule GLP-1 receptor agonists, situating them within a shifting landscape of obesity and type 2 diabetes care.
- 19 Jun 2026
Oral GLP-1 Drugs Emerge in Obesity and Diabetes Care
A comment published in The Lancet explores the therapeutic potential of oral small-molecule GLP-1 receptor agonists against a backdrop of shifting clinical priorities in obesity and type 2 diabetes management.
17 Jun 2026GLP-1 Microdosing for Weight Loss Draws Safety Concerns
A weight-loss doctor has raised concerns about the growing use of GLP-1 medications in small, so-called microdoses for cosmetic weight loss, warning that long-term safety data for this application remains absent.
13 Jun 2026Farm Bill Caps on Imports Could Remove Bananas From School Lunches
Proposed caps on imported foods under a new US Farm Bill could see bananas disappear from school cafeterias, with nutrition advocates warning the policy may undermine children's access to healthy, appealing meals.
9 Jun 2026Muscle Loss and Obesity Injections: What Research Shows
A notable proportion of weight lost through obesity injections such as Ozempic may come from muscle rather than fat, experts have warned, prompting efforts to develop a counteracting drug.
- 30 May 2026
GLP-1 Drugs and the Brain: What the Evidence Shows
GLP-1 receptor agonists, best known for managing blood sugar and body weight, are being studied across a widening range of conditions — including, tentatively, disorders of the central nervous system.
27 May 2026Grief, Nutrition and the Body's Own Signals
When one writer lost her husband to asbestos-related lung cancer, then her sister and father in close succession, her path back involved tuning in to what her body was telling her — a response that researchers are beginning to take seriously.